{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:42:00Z","timestamp":1793580120817,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFB3800900"],"award-info":[{"award-number":["2021YFB3800900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373299"],"award-info":[{"award-number":["52373299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["51973149"],"award-info":[{"award-number":["51973149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jconrel.2025.114576","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T22:53:27Z","timestamp":1766703207000},"page":"114576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Absorbable microspheres sustaining epirubicin and TLR7 agonist release for transarterial chemo-immuno-embolization in liver tumor"],"prefix":"10.1016","volume":"390","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiakun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hujing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.jconrel.2025.114576_bb0005","first-page":"229","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114576_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2025.114576_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.114576_bb0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114576_bb0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114576_bb0030","first-page":"1","article-title":"Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)","volume":"8","author":"Zhu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114576_bb0035","doi-asserted-by":"crossref","first-page":"18211","DOI":"10.1021\/acsnano.4c00047","article-title":"Biodegradable microembolics with nanografted polyanions enable high-efficiency drug loading and sustained deep-tumor drug penetration for locoregional chemoembolization treatment","volume":"18","author":"Ma","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114576_bb0040","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2024.01.072","article-title":"Locoregional drug delivery for cancer therapy: preclinical progress and clinical translation","volume":"367","author":"Shaha","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41578-023-00617-2","article-title":"Responsive biomaterials: optimizing control of cancer immunotherapy","volume":"9","author":"Xue","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0050","first-page":"1","article-title":"Engineering multi-specific nano-antibodies for cancer immunotherapy","volume":"10","author":"Fan","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2025.114576_bb0055","doi-asserted-by":"crossref","first-page":"22412","DOI":"10.1021\/jacs.5c00124","article-title":"Engineering of sono-activatable immunogels for immunometabolism disorder normalization therapy of breast cancer","volume":"147","author":"Guo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2025.114576_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113721","article-title":"Immunogenic cell death as interplay between physical anticancer modalities and immunotherapy","volume":"384","author":"Engelen","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0065","doi-asserted-by":"crossref","first-page":"2412141","DOI":"10.1002\/adma.202412141","article-title":"Spatiotemporal nano-regulator unleashes anti-tumor immunity by overcoming dendritic cell tolerance and T cell exhaustion in tumor-draining lymph nodes","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122573","article-title":"Polymeric micellar nanoparticles for effective CRISPR\/Cas9 genome editing in cancer","volume":"309","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","article-title":"Evolving therapeutic landscape of advanced hepatocellular carcinoma","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114576_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41419-024-06493-0","article-title":"Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer","volume":"15","author":"Xie","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.114576_bb0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jhep.2024.03.033","article-title":"Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment","volume":"81","author":"Chan","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114576_bb0090","doi-asserted-by":"crossref","first-page":"2417735","DOI":"10.1002\/adma.202417735","article-title":"Nanoparticle-mediated explosive anti-PD-L1 factory built in tumor for advanced immunotherapy","volume":"37","author":"Park","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114003","article-title":"Oncolytic microgels with regulated antibody release augment tumor immunotherapy","volume":"385","author":"Guo","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122480","article-title":"Hypoxia-activated cascade nanovaccine for synergistic chemoembolization-immune therapy of hepatocellular carcinoma","volume":"306","author":"Shi","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123018","article-title":"Pickering emulsion with tumor vascular destruction and microenvironment modulation for transarterial embolization therapy","volume":"316","author":"Zhang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2024.06.026","article-title":"Sustained release hypoxia-activated prodrug-loaded BSA nanoparticles enhance transarterial chemoembolization against hepatocellular carcinoma","volume":"372","author":"Hao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0115","doi-asserted-by":"crossref","first-page":"2408899","DOI":"10.1002\/advs.202408899","article-title":"Polymeric multivalent fc binding peptides-fabricated clinical compounding bispecific antibody potentiates dual immunotherapy targeting PD1 and CTLA-4","volume":"12","author":"Liu","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114576_bb0120","doi-asserted-by":"crossref","first-page":"2410873","DOI":"10.1002\/advs.202410873","article-title":"A lipiodol Pickering emulsion stabilized by iron-doped carbon nanozymes for liver transarterial chemoembolization","volume":"12","author":"Xia","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114576_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2025.01.088","article-title":"Self-assembling chemodrug fiber-hydrogel for transarterial chemoembolization and radiotherapy-enhanced antitumor immunity","volume":"380","author":"Peng","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0130","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1021\/acsnano.4c00227","article-title":"A redox-triggered autophagy-induced nanoplatform with PD-L1 inhibition for enhancing combined chemo-immunotherapy","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114576_bb0135","first-page":"299","article-title":"A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody","volume":"21","author":"Li","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113682","article-title":"PD-L1 targeted antibody-polymer-Epirubicin conjugate prolongs survival in a preclinical murine model of advanced ovarian cancer","volume":"382","author":"Li","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0145","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2024.06.041","article-title":"Resiquimod-loaded cationic liposomes cure mice with peritoneal carcinomatosis and induce specific anti-tumor immunity","volume":"372","author":"Chao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0150","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jconrel.2024.01.057","article-title":"Enhancing cell pyroptosis with biomimetic nanoparticles for melanoma chemo-immunotherapy","volume":"367","author":"Sun","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123527","article-title":"Precisely deliver toll-like receptor agonists using a dual-responsive nanovaccine for effective cancer immunotherapy","volume":"324","author":"Xing","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0160","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1038\/s41467-025-61621-4","article-title":"Tumor vessel-adaptable adhesive and absorbable microspheres for sustainable transarterial chemoembolization therapy","volume":"16","author":"Guo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114576_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123061","article-title":"Phycocyanin-based multifunctional microspheres for treatment of infected radiation-induced skin injury","volume":"317","author":"Dong","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0170","doi-asserted-by":"crossref","first-page":"2404299","DOI":"10.1002\/smll.202404299","article-title":"A redox-triggered polymeric nanoparticle for disrupting redox homeostasis and enhanced ferroptosis","volume":"21","author":"Li","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114576_bb0175","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jconrel.2022.12.001","article-title":"A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy","volume":"353","author":"Wen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2024.02.030","article-title":"Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief","volume":"368","author":"He","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114576_bb0185","article-title":"A trinity strategy: mesoporous platinum nanoparticles serve as a photoenhanced nanoplatform for tumor immunotherapy","volume":"495","author":"Wang","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2025.114576_bb0190","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.114576_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123000","article-title":"Bacteria-based biohybrids for remodeling adenosine-mediated immunosuppression to boost radiotherapy-triggered antitumor immune response","volume":"316","author":"Wu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2025.102835","article-title":"A nanoscale innate immune multiplier amplifies immunogenic cell death triggered by oxaliplatin via enhancing systemic and trained immunity","volume":"65","author":"Zhang","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2025.114576_bb0205","doi-asserted-by":"crossref","first-page":"2312360","DOI":"10.1002\/adfm.202312360","article-title":"An adhesive immune-stimulating multifunctional hydrogel for potent tumor chemoimmunotherapy and postoperative wound healing promotion","volume":"34","author":"Wang","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0210","first-page":"18","article-title":"Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity","volume":"2","author":"Ackerman","year":"2021","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2025.114576_bb0215","doi-asserted-by":"crossref","first-page":"2101651","DOI":"10.1002\/adhm.202101651","article-title":"Well-defined mannosylated polymer for peptide vaccine delivery with enhanced antitumor immunity","volume":"11","author":"Lv","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0220","article-title":"Long-acting in situ cancer vaccines by oncolytic sting-activating microgels","volume":"22","author":"Tan","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.114576_bb0225","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.actbio.2022.09.074","article-title":"Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model","volume":"154","author":"Wang","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.114576_bb0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.7150\/thno.45348","article-title":"Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2025.114576_bb0235","doi-asserted-by":"crossref","first-page":"eadv0885","DOI":"10.1126\/sciadv.adv0885","article-title":"Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: from animal models to a pilot clinical study","volume":"11","author":"Gong","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2025.114576_bb0240","volume":"72","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jconrel.2025.114576_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.123063","article-title":"Bioactive microspheres to enhance sonodynamic-embolization-metalloimmune therapy for orthotopic liver cancer","volume":"317","author":"Xu","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114576_bb0250","doi-asserted-by":"crossref","first-page":"2505770","DOI":"10.1002\/adma.202505770","article-title":"A gas nanobomb to promote drug penetration and amplify tace therapy for orthotopic liver tumor","volume":"38","author":"Chen","year":"2025","journal-title":"Adv. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925011903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:23:44Z","timestamp":1781702624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925011903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S0168365925011903"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114576","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorbable microspheres sustaining epirubicin and TLR7 agonist release for transarterial chemo-immuno-embolization in liver tumor","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114576","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114576"}}